13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001104659-25-112427
Total Value
$1.11B
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DIANTHUS THERAPEUTICS INC | DNTH | 3,307,191 | $130.1M | 11.71% |
| 2 | COGENT BIOSCIENCES INC | COGT | 9,003,418 | $129.3M | 11.63% |
| 3 | AXSOME THERAPEUTICS INC | AXSM | 815,176 | $99.0M | 8.91% |
| 4 | APOGEE THERAPEUTICS INC | APGE | 2,048,647 | $81.4M | 7.32% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 3,711,444 | $76.0M | 6.84% |
| 6 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,459,913 | $74.7M | 6.72% |
| 7 | ORUKA THERAPEUTICS INC | ORKA | 3,705,262 | $71.3M | 6.41% |
| 8 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 1,772,839 | $68.8M | 6.19% |
| 9 | SCHOLAR ROCK HLDG CORP | SRRK | 1,824,031 | $67.9M | 6.11% |
| 10 | SPYRE THERAPEUTICS INC | SYRE | 4,018,101 | $67.3M | 6.06% |
| 11 | NUVALENT INC | NUVL | 727,563 | $62.9M | 5.66% |
| 12 | ABIVAX SA | AAVXF | 713,434 | $60.6M | 5.45% |
| 13 | ZENAS BIOPHARMA INC | ZBIO | 1,892,806 | $42.0M | 3.78% |
| 14 | JADE BIOSCIENCES INC | JBIO | 3,220,368 | $27.8M | 2.50% |
| 15 | ASTRIA THERAPEUTICS INC | 04635X102 | 3,554,129 | $25.9M | 2.33% |
| 16 | CRESCENT BIOPHARMA INC. | CBIO | 1,387,866 | $16.5M | 1.48% |
| 17 | INHIBIKASE THERAPEUTICS INC | IKT | 6,125,000 | $9.9M | 0.89% |